{"id":"https://openalex.org/W4399605487","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.11509","title":"Molecular characterization of patients with localized Ewing sarcoma targeting discrete prognostic groups: A report from the Children\u2019s Oncology Group.","display_name":"Molecular characterization of patients with localized Ewing sarcoma targeting discrete prognostic groups: A report from the Children\u2019s Oncology Group.","publication_year":2024,"publication_date":"2024-06-01","ids":{"openalex":"https://openalex.org/W4399605487","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.11509"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.11509","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.11509","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.11509","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088682578","display_name":"Riaz Gillani","orcid":"https://orcid.org/0000-0001-8643-2725","observed_orcids":["https://orcid.org/0000-0001-8643-2725"]},"institutions":[{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Riaz Gillani","raw_affiliation_strings":["Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA","institution_ids":["https://openalex.org/I4210166317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023600635","display_name":"David Stephen Shulman","orcid":"https://orcid.org/0000-0002-5994-2604","observed_orcids":["https://orcid.org/0000-0002-5994-2604"]},"institutions":[{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Stephen Shulman","raw_affiliation_strings":["Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA","institution_ids":["https://openalex.org/I4210166317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065388955","display_name":"Kelly S. Klega","orcid":"https://orcid.org/0000-0002-3424-2003","observed_orcids":["https://orcid.org/0000-0002-3424-2003"]},"institutions":[{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly S. Klega","raw_affiliation_strings":["Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA","institution_ids":["https://openalex.org/I4210166317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043322584","display_name":"Natalie J. DelRocco","orcid":"https://orcid.org/0000-0002-8139-9839","observed_orcids":["https://orcid.org/0000-0002-8139-9839"]},"institutions":[{"id":"https://openalex.org/I4210134079","display_name":"Children's Oncology Group","ror":"https://ror.org/03yyg2352","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210134079"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Natalie J. DelRocco","raw_affiliation_strings":["Children's Oncology Group, Monrovia, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Oncology Group, Monrovia, CA","institution_ids":["https://openalex.org/I4210134079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090325707","display_name":"Mark Krailo","orcid":"https://orcid.org/0000-0002-7608-0698","observed_orcids":["https://orcid.org/0000-0002-7608-0698"]},"institutions":[{"id":"https://openalex.org/I4210134079","display_name":"Children's Oncology Group","ror":"https://ror.org/03yyg2352","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210134079"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark D. Krailo","raw_affiliation_strings":["Children's Oncology Group, Arcadia, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Oncology Group, Arcadia, CA","institution_ids":["https://openalex.org/I4210134079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081085707","display_name":"Ruxu Han","orcid":"https://orcid.org/0000-0003-0991-2404","observed_orcids":["https://orcid.org/0000-0003-0991-2404"]},"institutions":[{"id":"https://openalex.org/I4210134079","display_name":"Children's Oncology Group","ror":"https://ror.org/03yyg2352","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210134079"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruxu Han","raw_affiliation_strings":["Children's Oncology Group, Monrovia, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Oncology Group, Monrovia, CA","institution_ids":["https://openalex.org/I4210134079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067062563","display_name":"Jonathan C. Slack","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Slack","raw_affiliation_strings":["Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5099112829","display_name":"Victoria Bainer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victoria Bainer","raw_affiliation_strings":["Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA","institution_ids":["https://openalex.org/I4210166317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014437784","display_name":"Jessica L. Armstrong","orcid":"https://orcid.org/0000-0003-2456-3628","observed_orcids":["https://orcid.org/0000-0003-2456-3628"]},"institutions":[{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica Armstrong","raw_affiliation_strings":["Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA","institution_ids":["https://openalex.org/I4210166317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046068707","display_name":"Alanna J. Church","orcid":"https://orcid.org/0000-0002-4835-5770","observed_orcids":["https://orcid.org/0000-0002-4835-5770"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alanna J. Church","raw_affiliation_strings":["Boston Children's Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston Children's Hospital, Boston, MA","institution_ids":["https://openalex.org/I1288882113"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009997118","display_name":"Brian D. Crompton","orcid":"https://orcid.org/0000-0001-9404-6621","observed_orcids":["https://orcid.org/0000-0001-9404-6621"]},"institutions":[{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian D. Crompton","raw_affiliation_strings":["Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA","institution_ids":["https://openalex.org/I4210166317"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056053037","display_name":"Katherine A. Janeway","orcid":"https://orcid.org/0000-0001-6000-3594","observed_orcids":["https://orcid.org/0000-0001-6000-3594"]},"institutions":[{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine A. Janeway","raw_affiliation_strings":["Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA","institution_ids":["https://openalex.org/I4210166317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"16_suppl","first_page":"11509","last_page":"11509"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11213","display_name":"Genomic variations and chromosomal abnormalities","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ewing-sarcoma","display_name":"Ewing sarcoma","score":0.9760000109672546},{"id":"https://openalex.org/keywords/copy-number-alterations","display_name":"copy number alterations","score":0.7799999713897705},{"id":"https://openalex.org/keywords/chromosome-1q-gain","display_name":"chromosome 1q gain","score":0.9369999766349792},{"id":"https://openalex.org/keywords/chromosome-8-gain","display_name":"chromosome 8 gain","score":0.8569999933242798},{"id":"https://openalex.org/keywords/chromosome-16q-loss","display_name":"chromosome 16q loss","score":0.8849999904632568},{"id":"https://openalex.org/keywords/stag2-mutation","display_name":"STAG2 mutation","score":0.7429999709129333},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.9829999804496765},{"id":"https://openalex.org/keywords/risk-of-relapse","display_name":"relapse risk","score":0.7860000133514404},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.871999979019165},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.8339999914169312},{"id":"https://openalex.org/keywords/secondary-malignancies","display_name":"secondary malignancies","score":0.578000009059906}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8729017376899719},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5481340289115906},{"id":"https://openalex.org/C2909143077","wikidata":"https://www.wikidata.org/wiki/Q5097977","display_name":"Pediatric oncology","level":3,"score":0.5348122715950012},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5334731936454773},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.5231772065162659},{"id":"https://openalex.org/C2777586341","wikidata":"https://www.wikidata.org/wiki/Q1138580","display_name":"Ewing's sarcoma","level":3,"score":0.5022556781768799},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.26785117387771606},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2621530294418335},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.23823678493499756}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2024.42.16_suppl.11509","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.11509","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.11509","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4415826647","https://openalex.org/W7166863478","https://openalex.org/W4416411992","https://openalex.org/W1994568630","https://openalex.org/W4386603422","https://openalex.org/W1984039839","https://openalex.org/W4211227438","https://openalex.org/W2162996009","https://openalex.org/W2124328974","https://openalex.org/W4214750914"],"abstract_inverted_index":{"11509":[0],"Background:":[1],"Ewing":[2],"sarcoma":[3],"(EWS)":[4],"is":[5],"an":[6,117],"aggressive":[7],"bone":[8],"and":[9,17,33,62,87,116,130,144,160,167,194,220,315,367,391],"soft":[10],"tissue":[11],"cancer":[12],"that":[13,196],"primarily":[14],"affects":[15],"adolescents":[16],"young":[18],"adults.":[19],"All":[20],"patients":[21,28,70,93,400,438],"receive":[22],"intensive":[23],"therapy,":[24],"yet":[25],"20%":[26],"of":[27,69,83,111,122,150,192,204,218,226,238,253,282,287,310,317,333,376,422,432],"with":[29,37,71,94,171,181,251,255,259,263,267,308,312,319,329,348,372,401,439],"localized":[30,72,403,419,440],"disease":[31],"die":[32],"survivors":[34],"are":[35,42,397],"left":[36],"significant":[38],"morbidity.":[39],"Molecular":[40],"biomarkers":[41],"needed":[43],"to":[44,48,212,232,410],"inform":[45],"risk-stratified":[46],"approaches":[47],"therapy.":[49],"We":[50,75,405],"thus":[51],"evaluated":[52],"gene":[53,187],"fusions,":[54],"copy":[55],"number":[56],"alterations":[57],"(CNAs),":[58],"mutations,":[59,307],"immunohistochemistry":[60],"(IHC),":[61],"relapse":[63,205,283,288,334,377],"risk":[64,416],"in":[65,418,425,437],"a":[66,81,109,112,185,234,278,412],"large":[67],"cohort":[68],"EWS.":[73,404,420,441],"Methods:":[74],"carried":[76],"out":[77],"targeted":[78,113,152],"sequencing":[79,139],"on":[80,98],"combination":[82,110],"Formalin-Fixed":[84],"Paraffin-Embedded":[85],"(FFPE)":[86],"frozen":[88],"tumor":[89],"specimens":[90],"from":[91],"351":[92,227],"EWS":[95,236],"previously":[96],"enrolled":[97],"cooperative":[99],"group":[100],"trials":[101,428],"(AEWS0031,":[102],"AEWS1031).":[103],"Gene":[104],"fusions":[105],"were":[106,133,146,176,189,200,230,247,304,362],"identified":[107,147],"using":[108,135],"DNA":[114,153],"assay":[115],"RNA":[118],"fusion":[119,237],"panel.":[120],"CNAs":[121],"chromosome":[123,273],"1q":[124,256,274],"gain,":[125,127,129,257,261,265],"8":[126,260],"12":[128,264],"16q":[131,268],"loss":[132,369,393],"ascertained":[134],"ultra-low":[136],"pass":[137],"whole-genome":[138],"(~0.1X":[140],"coverage).":[141],"Deleterious":[142],"STAG2":[143,159,320,325,365,368,389,392],"TP53mutations":[145],"as":[148,162,178,208],"part":[149],"the":[151,209,215],"assay.":[154],"Tissue":[155],"was":[156,206,327,345,370],"stained":[157],"for":[158,214,249,306,364,414],"scored":[161],"percent":[163],"0,":[164],"1+,":[165],"2+":[166,173],"3+":[168,175],"staining.":[169],"Tumors":[170],"\u226550%":[172,182],"or":[174,184,242],"considered":[177,190],"\u201cexpressed\u201d,":[179],"those":[180,195],"0":[183],"deleterious":[186],"alteration":[188],"\u201closs":[191],"expression\u201d,":[193],"fit":[197],"neither":[198],"criterion":[199],"\u201cindeterminate.\u201d":[201],"Cumulative":[202],"incidence":[203,281,286,332,375],"used":[207],"outcome":[210,350],"measure":[211],"account":[213],"competing":[216],"risks":[217],"death":[219],"secondary":[221],"malignant":[222],"neoplasm.":[223],"Results:":[224],"282":[225],"cases":[228,245,254,302,311,318,360],"(80.3%)":[229],"found":[231],"have":[233],"canonical":[235],"EWSR1-FLI1,":[239],"EWSR1-ERG,":[240],"EWSR1-ETV,":[241],"EWSR1-FEV.":[243],"247":[244],"(87.6%)":[246],"evaluable":[248,305,363],"CNAs,":[250],"20.6%":[252],"50.6%":[258],"21.1%":[262],"17.0%":[266],"loss.":[269],"In":[270,322],"univariate":[271,323],"analyses,":[272,324],"gain":[275],"trended":[276],"toward":[277],"higher":[279,330,373],"cumulative":[280,285,331,374],"(5-year":[284],"35%,":[289],"95%":[290],"C.I.":[291],"[23%,49%]":[292],"vs.":[293,337,353,380],"21%,":[294,338],"[16%,28%];":[295],"Gray\u2019s":[296],"test":[297],"p":[298,340,356,383],"=":[299,357,384],"0.063).":[300],"277":[301],"(98.2%)":[303],"5.1%":[309],"TP53":[313,343,387],"mutations":[314],"7.6%":[316],"mutations.":[321],"mutation":[326,344,396],"associated":[328,347,371],"(53%,":[335],"[29%,73%]":[336],"[16%,26%];":[339],"<":[341],"0.001).":[342],"also":[346],"worse":[349],"(43%,":[351],"[17%,67%]":[352],"22%,":[354],"[17%,27%];":[355],"0.039).":[358],"169":[359],"(59.9%)":[361],"IHC,":[366],"(32%,":[378],"[20%,45%]":[379],"16%,":[381],"[9.6%,25%];":[382],"0.004).":[385],"Conclusions:":[386],"mutation,":[388,390],"by":[394],"IHC/":[395],"prognostic":[398],"among":[399],"primary":[402],"will":[406],"use":[407],"these":[408,423],"data":[409],"develop":[411],"framework":[413],"molecular":[415],"stratification":[417],"Integration":[421],"findings":[424],"future":[426],"clinical":[427],"may":[429],"allow":[430],"testing":[431],"biologically":[433],"informed":[434],"treatment":[435],"modification":[436]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2024-06-14T00:00:00"}